SRC and breast carcinoma: Previously, the anti-proliferative effects of DADS on breast cancer cells were investigated, and the results showed that DADS inhibited MDA-MB-231 cell proliferation, migration, and invasion and in vivo tumorigenicity by inhibiting Src, which consequently triggered the suppression of the SRC/Ras/ERK signaling pathway.